Alzheimer’s disease, known as Alzheimer’s disease, is a degenerative disease of the nervous system.
Clinically, it is manifested as general dementia such as memory impairment, aphasia, apraxia, ignorance, impairment of visual spatial skills, executive dysfunction, and personality and behavior changes.
Recently, Dr. Paul Harch, clinical professor and director of hyperbaric oxygen medicine at Louisiana State University Health New Orleans School of Medicine, and Dr. Edward Fogarty, director of the Department of Radiology at North Dakota Medical College, reported the first case of PET scan recorded with hyperbaric oxygen therapy (HBOT) treatment A case of improved brain metabolism in Alzheimer’s disease patients.
In the report, a 58-year-old female patient received 40 hyperbaric oxygen treatments, 5 days a week, for a total of 66 days.
At 1.15 atmospheres/50 minutes each time, after 21 treatments, the patient reported increased energy and activity levels, better mood, improved daily life and crossword skills
After 40 treatments, she reported that memory and concentration, sleep, conversation, appetite, and the ability to use computers have increased. There are more good days (5/7) than bad days, which resolves anxiety and reduces disorientation and disorientation. Frustrated. Tremor, deep knee flexion, tandem gain, and movement speed have also been improved.
FDG PET imaging repeated 18 times a month after HBOT treatment showed an overall improvement in brain metabolism by 6.5-38%.
Therefore, Dr. Harch believes:
Hyperbaric oxygen therapy can not only stop, but also temporarily reverse the development of Alzheimer’s disease.
Resource (https://zhuanlan.zhihu.com/p/86718051)
Researchers from Tel Aviv University published an article in “Neurobiology of Aging”, new research results show that hyperbaric oxygen therapy can effectively correct Alzheimer’s disease-related physical and behavioral disorders
Biotech: Many targeted drugs for Alzheimer’s disease have failed in clinical trials. This not only makes us ask, can this very common aging-related disease be cured?
Recently, researchers from Tel Aviv University published an article in “Neurobiology of Aging”. New research results show that hyperbaric oxygen therapy can effectively correct the physiological and behavioral disorders related to Alzheimer’s disease. Professor Uri Ashery, professor of neuroscience and life sciences at Tel Aviv University, said: “The experimental results obtained in the hyperbaric oxygen chamber treatment of Alzheimer’s disease are revolutionary. This type of physical therapy has been proven to be safe and effective in treating slow healing of wounds. For the first time, it has been proved to be applicable to Alzheimer’s disease treatment, which is very exciting.”
Hyperbaric oxygen therapy increases the patient’s blood oxygen concentration by two times the normal value. The rich oxygen dissolved in the blood can stimulate the release of growth factors and stem cells, which are all conducive to promoting healing.
The scientists used an Alzheimer’s mouse model and created a special hyperoxia chamber suitable for small animals. The researchers let the mice stay in the hyperoxia chamber for 1 hour every day, and then performed a series of behavioral tests and tissue biochemical tests on the mice after 14 consecutive days.
Compared with control mice and healthy mice, the behavioral defects of the treated mice with genetically modified diseases were significantly improved, pathological plaques were reduced by 40%, and neuroinflammation was also reduced by about 40%.
“Hyperbaric oxygen therapy has been proven to be a safe and conventional method for the treatment of many diseases (especially neurological diseases), and it is widely used all over the world. Although we still need to conduct more in-depth research on the mechanism, Phenomenally we have seen its improvement effect,” said Ronit Shapira, the main participant of the study.
Researchers are currently testing the therapeutic effect of hyperbaric oxygen therapy on another mouse model of Alzheimer’s disease to explore its specific mechanism for disease control.
Previously, we also reported that a nutritional drink developed by the team of Professor Richard Wurtman has a better function of reversing the condition of early Alzheimer’s disease (two articles in Lancet Neurology, heavy report: the most promising Alzheimer’s Alzheimer’s disease treatment drink!). Before this complex disease mechanism is completely unraveled, these non-drug and non-invasive treatment strategies will be of more substantial help to the majority of patients and their families.
Resource (http://www.ebiotrade.com/newsf/2017-12/2017126135918662.htm)